Dataset of the DROP project, with relevant variables for the cost-effectiveness study. For details about this research project, see the study protocol in: Aragonès, E., López-Cortacans, G., Caballero,
IntroductionPatients with a penicillin allergy label (PAL) use more and broader-spectrum antibiotics, have worse health outcomes and cost more to treat than patients without a PAL. A significant propo
BackgroundSelf-reported data are often used for estimates on healthcare utilization in cost-effectiveness studies.ObjectiveTo analyze older adults’ self-report of healthcare utilization compared to da
Background Expanding the indication of already approved immuno-oncology drugs presents treatment opportunities for patients but also strains healthcare systems. Cost-based pricing models are discussed
In this work, we aimed to assess the impact of clazosentan on clinical labour time costs within Japan’s value-based healthcare system using time-driven activity-based costing. Time-driven activity-bas
